Cargando…
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Background: Treatment outcomes are poorly characterized in patients with metastatic chromophobe renal cell cancer (chrRCC), a subtype of renal cell carcinoma. Objective: This retrospective series aims to determine metastatic chrRCC treatment outcomes in the targeted therapy era. Methods: A retrospec...
Autores principales: | Yip, Steven M., Ruiz Morales, Jose M., Donskov, Frede, Fraccon, Anna, Basso, Umberto, Rini, Brian I., Lee, Jae Lyun, Bjarnason, Georg A., Sim, Hao-Wen, Beuselinck, Benoit, Kanesvaran, Ravindran, Brugarolas, James, Koutsoukos, Kostas, Fu, Simon Yuen Fai, Yuasa, Takeshi, Davis, Ian, Alva, Ajjai, Kollmannsberger, Christian, Choueiri, Toni K., Heng, Daniel Y.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179119/ https://www.ncbi.nlm.nih.gov/pubmed/30334003 http://dx.doi.org/10.3233/KCA-160002 |
Ejemplares similares
-
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival
por: Dudani, Shaan, et al.
Publicado: (2021) -
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
por: Ko, J J, et al.
Publicado: (2014) -
Characterizing the outcomes of metastatic papillary renal cell carcinoma
por: Connor Wells, John, et al.
Publicado: (2017) -
Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms
por: Labaki, Chris, et al.
Publicado: (2023) -
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)